Comparison of Steroid Dosages on the Efficacy of Trochanteric Bursa Injection
Status: | Recruiting |
---|---|
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 7/11/2015 |
Start Date: | April 2014 |
End Date: | June 2016 |
Contact: | Chong H Kim, MD |
Email: | kimc@wvuhealthcare.com |
Phone: | 304 598 6216 |
Prospective, Randomized, Double-blinded Comparison of Steroid Dosages on the Efficacy of Trochanteric Bursa Injection
Inflammation of the trochanteric bursa is a common cause of hip pain. A bursa is a closed
fluid filled sac or sac-like cavity found between tissues that function as a gliding surface
to reduce friction. Bursitis is the inflammation of the bursa. Inflammation between the
trochanteric process of the femur and gluteus medius tendon/ iliotibial tract is the cause
of trochanteric bursitis. Several treatments exist for trochanteric bursitis, including a
local steroid injection. The injection consists of a mixture of local anesthetic and steroid
medications. The steroid is routinely mixed with a local anesthetic. The anesthetic acts to
diluent the steroid as well as act as a pain reliever. Various steroid preparations have
been used, at varying doses, for trochanteric bursitis. The steroid preparation,
triamcinolone is commonly used for various reasons. Besides the procedure associated and
injection site risks, risks associated with the use of steroids, though rare, exist. Short
term, the steroid can raise blood sugar levels and should be used with caution and be
appropriately monitored in diabetics. Additionally, the steroid can suppress the immune
system. Long-term risks are related to the dose and frequency of use. These risks include
thinning of the skin, easy bruising, weight gain, elevated blood pressure, cataract
formation, thinning of bones and joints. Studies have shown the effectiveness of local
steroid injections for trochanteric bursitis. Unfortunately, there is limited data on the
ideal dose of the steroid preparation. Triamcinolone of 40mg/ mL is commonly used, but,
studies have shown effectiveness at various doses, ranging 20 to 160 mg/mL. The aim of this
study is to evaluate and compare the effectiveness of local steroid injections of various
steroid dosages for the treatment of trochanteric bursitis.
fluid filled sac or sac-like cavity found between tissues that function as a gliding surface
to reduce friction. Bursitis is the inflammation of the bursa. Inflammation between the
trochanteric process of the femur and gluteus medius tendon/ iliotibial tract is the cause
of trochanteric bursitis. Several treatments exist for trochanteric bursitis, including a
local steroid injection. The injection consists of a mixture of local anesthetic and steroid
medications. The steroid is routinely mixed with a local anesthetic. The anesthetic acts to
diluent the steroid as well as act as a pain reliever. Various steroid preparations have
been used, at varying doses, for trochanteric bursitis. The steroid preparation,
triamcinolone is commonly used for various reasons. Besides the procedure associated and
injection site risks, risks associated with the use of steroids, though rare, exist. Short
term, the steroid can raise blood sugar levels and should be used with caution and be
appropriately monitored in diabetics. Additionally, the steroid can suppress the immune
system. Long-term risks are related to the dose and frequency of use. These risks include
thinning of the skin, easy bruising, weight gain, elevated blood pressure, cataract
formation, thinning of bones and joints. Studies have shown the effectiveness of local
steroid injections for trochanteric bursitis. Unfortunately, there is limited data on the
ideal dose of the steroid preparation. Triamcinolone of 40mg/ mL is commonly used, but,
studies have shown effectiveness at various doses, ranging 20 to 160 mg/mL. The aim of this
study is to evaluate and compare the effectiveness of local steroid injections of various
steroid dosages for the treatment of trochanteric bursitis.
Inclusion Criteria:
1. Clinical diagnosis of trochanteric bursitis
2. 18 years of age or older when written informed consent is obtained
3. Signed institutional review board approved informed consent form
Exclusion Criteria:
1. Meets any contraindication for treatment
2. Allergy to triamcinolone, lidocaine
3. Previous surgery to bursa
4. Coagulopathy
5. Active Infection
6. Currently diagnosed with cognitive impairment, or exhibits any characteristic, that
would limit study candidate's ability to assess pain relief or complete study
assessments
We found this trial at
1
site
1 Medical Center Drive
Morgantown, West Virginia 26506
Morgantown, West Virginia 26506
304-598-4800
West Virginia University Hospitals Inc. WVU Healthcare is two corporations, University Health Associates and WVU...
Click here to add this to my saved trials